Avelumab in Previously Untreated Patients with Epithelial Ovarian Cancer (Javelin Ovarian 100)
A Randomized, Open-Label, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Avelumab (MSB0010718C) in Combination With and/or Following Chemotherapy in Patients With Previously Untreated Epithelial Ovarian Cancer
Category & Conditions: Cancer
Medicine: BAVENCIO(AVELUMAB)
ClinicalTrials.gov Identifier (NCT): NCT02718417
Protocol ID: B9991010
PrintDownloadOpen Plain Language Summary Result: Click here